• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西血液学、血液疗法与细胞疗法协会关于患者血液管理的共识:术后贫血的评估与管理

Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Assessment and management of postoperative anemia.

作者信息

Benites Bruno Deltreggia, Magnus Mariana Munari, Costa Lorena, Brunetta Denise Menezes, Rodriges Roseny Dos Reis, Alves Susankerle de Oliveira Costa, De Santis Gil Cunha, Rizzo Silvia Renata Cornélio Parolin, Rabello Guilherme, Junior Dante Mario Langhi

机构信息

Centro de Hematologia e Hemoterapia da Universidade Estadual de Campinas (Hemocentro UNICAMP), Campinas, SP, Brazil.

Universidade de Pernambuco (UPE), Recife, PE, Brazil.

出版信息

Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S72-S76. doi: 10.1016/j.htct.2024.02.014. Epub 2024 Mar 19.

DOI:10.1016/j.htct.2024.02.014
PMID:38580494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11069069/
Abstract

Postoperative anemia is a complex clinical issue that requires attention due to its ramifications on the patient's recovery and prognosis. Originating from multiple determinants, such as intraoperative blood loss, hemolysis, nutritional deficiencies, systemic inflammation and impact on the bone marrow, postoperative anemia has varied and often challenging presentations. Patients undergoing major surgical procedures, in particular, are susceptible to developing anemia due to the considerable associated blood loss. Accurate diagnosis plays a crucial role in the approach, requiring meticulous hematological analysis, including hemoglobin, hematocrit and reticulocyte count, as well as an in-depth investigation of the underlying causes. An additional challenge arises in the form of the excessive practice of phlebotomy during hospitalization for clinical monitoring. Although it is essential to assess the progression of anemia, frequent removal of blood may contribute to iatrogenic anemia, further delaying recovery and possibly increasing susceptibility to infection.

摘要

术后贫血是一个复杂的临床问题,因其对患者恢复和预后的影响而需要引起关注。术后贫血源于多种因素,如术中失血、溶血、营养缺乏、全身炎症以及对骨髓的影响,其表现多样且往往具有挑战性。特别是接受大型外科手术的患者,由于术中大量失血,容易发生贫血。准确诊断在处理过程中起着关键作用,这需要细致的血液学分析,包括血红蛋白、血细胞比容和网织红细胞计数,以及对潜在病因的深入调查。住院期间因临床监测而过度进行静脉放血的做法带来了另一个挑战。虽然评估贫血进展至关重要,但频繁采血可能导致医源性贫血,进一步延迟恢复,并可能增加感染易感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8835/11069069/2a920fd7f676/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8835/11069069/2a920fd7f676/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8835/11069069/2a920fd7f676/gr1.jpg

相似文献

1
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Assessment and management of postoperative anemia.巴西血液学、血液疗法与细胞疗法协会关于患者血液管理的共识:术后贫血的评估与管理
Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S72-S76. doi: 10.1016/j.htct.2024.02.014. Epub 2024 Mar 19.
2
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Acute normovolemic hemodilution and intraoperative autotransfusion.巴西血液学、血液治疗与细胞治疗协会关于患者血液管理的共识:急性等容血液稀释与术中自体输血
Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S48-S52. doi: 10.1016/j.htct.2024.02.019. Epub 2024 Mar 27.
3
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Preoperative Phase - Preoperative management of the patient's anemia.巴西血液学、血液疗法和细胞疗法协会关于患者血液管理的共识:术前阶段——患者贫血的术前管理
Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S17-S23. doi: 10.1016/j.htct.2024.02.006. Epub 2024 Mar 11.
4
Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.微创和传统心胸外科手术中血液管理的药物、器械、技术与方法:国际微创心胸外科协会(ISMICS)2011年共识声明
Innovations (Phila). 2012 Jul-Aug;7(4):229-41. doi: 10.1097/IMI.0b013e3182747699.
5
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Anemia tolerance.巴西血液学、血液治疗与细胞治疗协会关于患者血液管理的共识:贫血耐受性
Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S67-S71. doi: 10.1016/j.htct.2024.02.018. Epub 2024 Mar 21.
6
Where does preoperative erythropoietin therapy count? A mathematical perspective.术前促红细胞生成素治疗的作用体现在何处?一个数学视角。
Transfusion. 1999 Apr;39(4):392-5. doi: 10.1046/j.1537-2995.1999.39499235672.x.
7
[Hospital-acquired anemia: Facts, consequences and prevention].[医院获得性贫血:事实、后果及预防]
Transfus Clin Biol. 2016 Nov;23(4):185-191. doi: 10.1016/j.tracli.2016.07.005. Epub 2016 Aug 23.
8
[Objectives of a bloodless surgery program. A comparative study (major surgery vs. minor-medium surgery) in 51 Jehova's Witnesses patients].[无血手术计划的目标。对51名耶和华见证会患者进行的一项比较研究(大手术与中小手术)]
Ann Ital Chir. 2002 Mar-Apr;73(2):197-209; discussion 209-10.
9
[Foreign blood saving measures in orthopedic surgery].[骨科手术中的异体血节约措施]
Orthopade. 2007 Jun;36(6):537-43. doi: 10.1007/s00132-007-1096-1.
10
Erythropoietic therapy: cost efficiency and reimbursement.红细胞生成疗法:成本效益与报销
Am J Health Syst Pharm. 2007 Aug 15;64(16 Suppl 11):S19-29. doi: 10.2146/ajhp070246.

本文引用的文献

1
Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS).国际手术患者贫血管理共识会议(ICCAMS)推荐意见。
Ann Surg. 2023 Apr 1;277(4):581-590. doi: 10.1097/SLA.0000000000005721. Epub 2022 Sep 21.
2
Analysis of risk factors for perioperative complications in spine surgery.脊柱手术围手术期并发症的危险因素分析。
Sci Rep. 2022 Aug 23;12(1):14350. doi: 10.1038/s41598-022-18417-z.
3
Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions.
成人既往输注反应史与无既往输注反应史患者的不良事件与静脉铁剂制剂分析。
JAMA Netw Open. 2022 Mar 1;5(3):e224488. doi: 10.1001/jamanetworkopen.2022.4488.
4
Efficacy and Safety of Intravenous Iron Therapy for Treating Anaemia in Critically ill Adults: A Rapid Systematic Review With Meta-Analysis.静脉铁剂治疗危重症成人贫血的疗效和安全性:快速系统评价与荟萃分析。
Transfus Med Rev. 2022 Apr;36(2):97-106. doi: 10.1016/j.tmrv.2021.12.002. Epub 2021 Dec 24.
5
Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery.肥胖症手术后缺铁性贫血患者用福来铁(FDI)对比蔗糖铁(IS)的疗效和安全性。
Obes Surg. 2022 Mar;32(3):810-818. doi: 10.1007/s11695-021-05858-0. Epub 2022 Jan 8.
6
Ferric Carboxymaltose for Anemic Perioperative Populations: A Systematic Literature Review of Randomized Controlled Trials.羧麦芽糖铁用于贫血围手术期人群:随机对照试验的系统文献综述
J Blood Med. 2021 May 26;12:337-359. doi: 10.2147/JBM.S295041. eCollection 2021.
7
A Narrative Review on Hospital-Acquired Anemia: Keeping Blood where It Belongs.关于医院获得性贫血的叙述性综述:让血液归位。
Transfus Med Rev. 2020 Jul;34(3):195-199. doi: 10.1016/j.tmrv.2020.03.003. Epub 2020 Mar 30.
8
Perioperative anemia: Prevalence, consequences and pathophysiology.围手术期贫血:患病率、后果及病理生理学
Transfus Apher Sci. 2019 Aug;58(4):369-374. doi: 10.1016/j.transci.2019.06.011. Epub 2019 Jul 5.
9
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.癌症相关性贫血的管理:ASCO/ASH 临床实践指南更新。
J Clin Oncol. 2019 May 20;37(15):1336-1351. doi: 10.1200/JCO.18.02142. Epub 2019 Apr 10.
10
Long-Term Outcomes Among Patients Discharged From the Hospital With Moderate Anemia: A Retrospective Cohort Study.伴有中度贫血的患者出院后的长期结局:一项回顾性队列研究。
Ann Intern Med. 2019 Jan 15;170(2):81-89. doi: 10.7326/M17-3253. Epub 2018 Dec 18.